Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease models
Version of Record online: 23 AUG 2013
© 2013 The Authors. FEBS Journal published by John Wiley & Sons Ltd on behalf of FEBS
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
The FEBS Journal
Volume 280, Issue 19, pages 4876–4887, October 2013
How to Cite
Déruaz, M., Bonvin, P., Severin, I. C., Johnson, Z., Krohn, S., Power, C. A. and Proudfoot, A. E. I. (2013), Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease models. The FEBS Journal, 280: 4876–4887. doi: 10.1111/febs.12463
M. Déruaz and P. Bonvin contributed equally to this work
- Issue online: 17 SEP 2013
- Version of Record online: 23 AUG 2013
- Accepted manuscript online: 2 AUG 2013 10:47AM EST
- Manuscript Accepted: 29 JUL 2013
- Manuscript Revised: 26 JUL 2013
- Manuscript Received: 21 MAY 2013
- European Union Seventh Framework Programme. Grant Numbers: FP7-2007-2013, HEALTH-F4-2011-281608
Fig. S1. Sequences of Evasin-4 constructs.
Fig. S2. CC chemokines recognized by Evasin-4.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.